Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia.
Spomenka Kiđemet-PiskačMirjana Babić LekoAntonela BlažekovićLea Langer HorvatNataša KlepacZdenko SonickiDanijela KolencPatrick R HofMarina BobanNinoslav MimicaFran BorovečkiGoran ŠimićPublished in: CNS neuroscience & therapeutics (2018)
These results indicate that FS (p-tau231 and MMSE) has a strong potential to provide an early distinction between AD and VaD.